-
1
-
-
0034802566
-
Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats
-
DOI 10.1053/jhep.2001.28231
-
H Yoshiji S Kuriyama J Yoshii Y Ikenaka R Noguchi T Nakatani 2001 Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats Hepatology. 34 745 750 (Pubitemid 32927999)
-
(2001)
Hepatology
, vol.34
, Issue.4
, pp. 745-750
-
-
Yoshiji, H.1
Kuriyama, S.2
Yoshii, J.3
Ikenaka, Y.4
Noguchi, R.5
Nakatani, T.6
Tsujinoue, H.7
Fukui, H.8
-
3
-
-
0025827178
-
Immunohistochemical detection of transforming growth factor-beta 1 in fibrotic liver diseases
-
P Nagy Z Scaff K Lapis 1991 Immunohistochemical detection of transforming growth factor-beta 1 in fibrotic liver diseases Hepatology. 14 269 273
-
(1991)
Hepatology.
, vol.14
, pp. 269-273
-
-
Nagy, P.1
Scaff, Z.2
Lapis, K.3
-
4
-
-
0025272893
-
Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor β: Implication for a pathogenetic role in alcoholic liver fibrogenesis
-
DOI 10.1002/hep.1840110412
-
M Matsuoka H Tsukamoto 1990 Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis Hepatology. 11 599 605 (Pubitemid 20151737)
-
(1990)
Hepatology
, vol.11
, Issue.4
, pp. 599-605
-
-
Matsuoka, M.1
Tsukamoto, H.2
-
5
-
-
18644369234
-
Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C
-
Y Terui T Saito H Watanabe H Togashi S Kawata Y Kamada 2002 Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C Hepatology 36 1022
-
(2002)
Hepatology
, vol.36
, pp. 1022
-
-
Terui, Y.1
Saito, T.2
Watanabe, H.3
Togashi, H.4
Kawata, S.5
Kamada, Y.6
-
6
-
-
7044222556
-
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
-
DOI 10.1002/hep.20420
-
S Yokohama M Yoneda M Haneda S Okamoto M Okada K Aso 2004 Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis Hepatology. 40 1222 1225 (Pubitemid 39425579)
-
(2004)
Hepatology
, vol.40
, Issue.5
, pp. 1222-1225
-
-
Yokohama, S.1
Yoneda, M.2
Haneda, M.3
Okamoto, S.4
Okada, M.5
Aso, K.6
Hasegawa, T.7
Tokusashi, Y.8
Miyokawa, N.9
Nakamura, K.10
-
7
-
-
34247633516
-
AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markers
-
DOI 10.1016/j.jhep.2007.01.017, PII S0168827807000657
-
W Debernardi-Venon S Martini F Biasi B Vizio A Termine G Poli 2007 AT1 receptor antagonist candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers J Hepatol 46 1026 1033 (Pubitemid 46669730)
-
(2007)
Journal of Hepatology
, vol.46
, Issue.6
, pp. 1026-1033
-
-
Debernardi-Venon, W.1
Martini, S.2
Biasi, F.3
Vizio, B.4
Termine, A.5
Poli, G.6
Brunello, F.7
Alessandria, C.8
Bonardi, R.9
Saracco, G.10
Rizzetto, M.11
Marzano, A.12
-
8
-
-
0031458429
-
Involvement of angiotensin II in cardiovascular and renal injury: Effects of an AT1-receptor antagonist on gene expression and the cellular phenotype
-
S Kim H Iwao 1997 Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype J Hypertens Suppl 15 S3 S7
-
(1997)
J Hypertens Suppl
, vol.15
-
-
Kim, S.1
Iwao, H.2
-
9
-
-
0346057802
-
Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist
-
DOI 10.1136/thx.2003.000893
-
M Otsuka H Takahashi M Shiratori H Chiba S Abe 2004 Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist Thorax. 59 31 38 (Pubitemid 38067969)
-
(2004)
Thorax
, vol.59
, Issue.1
, pp. 31-38
-
-
Otsuka, M.1
Takahashi, H.2
Shiratori, M.3
Chiba, H.4
Abe, S.5
-
11
-
-
0141630677
-
Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats
-
DOI 10.1124/jpet.103.053322
-
T Yamada A Kuno K Masuda K Ogawa M Sogawa S Nakamura 2003 Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats J Pharmacol Exp Ther 307 17 23 (Pubitemid 37151887)
-
(2003)
Journal of Pharmacology and Experimental Therapeutics
, vol.307
, Issue.1
, pp. 17-23
-
-
Yamada, T.1
Kuno, A.2
Masuda, K.3
Ogawa, K.4
Sogawa, M.5
Nakamura, S.6
Ando, T.7
Sano, H.8
Nakazawa, T.9
Ohara, H.10
Nomura, T.11
Joh, T.12
Itoh, M.13
-
12
-
-
0028792103
-
Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist
-
M Mizuno T Sada M Ikeda N Fukuda M Miyamoto H Yanagisawa 1995 Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist Eur J Pharmacol 285 181 188
-
(1995)
Eur J Pharmacol
, vol.285
, pp. 181-188
-
-
Mizuno, M.1
Sada, T.2
Ikeda, M.3
Fukuda, N.4
Miyamoto, M.5
Yanagisawa, H.6
-
13
-
-
0034760610
-
Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension
-
(318)
-
S Oparil D Williams SG Chrysant TC Marbury J Neutel 2001 Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension J Clin Hypertens (Greenwich) 3 283 291 (318)
-
(2001)
J Clin Hypertens (Greenwich)
, vol.3
, pp. 283-291
-
-
Oparil, S.1
Williams, D.2
Chrysant, S.G.3
Marbury, T.C.4
Neutel, J.5
-
14
-
-
0029878808
-
1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis
-
Y Murawaki Y Ikuta Y Nishimura M Koda H Kawasaki 1996 Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis J Gastroenterol Hepatol 11 443 450 (Pubitemid 26153350)
-
(1996)
Journal of Gastroenterology and Hepatology
, vol.11
, Issue.5
, pp. 443-450
-
-
Murawaki, Y.1
Ikuta, Y.2
Nishimura, Y.3
Koda, M.4
Kawasaki, H.5
-
15
-
-
0028301747
-
Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma: Comparison with chronic liver diseases
-
Y Shirai S Kawata S Tamura N Ito H Tsushima K Takaishi 1994 Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases Cancer. 73 2275 2279 (Pubitemid 24129108)
-
(1994)
Cancer
, vol.73
, Issue.9
, pp. 2275-2279
-
-
Shirai, Y.1
Kawata, S.2
Tamura, S.3
Ito, N.4
Tsushima, H.5
Takaishi, K.6
Kiso, S.7
Matsuzawa, Y.8
-
16
-
-
0023030542
-
Hemodynamic evaluation of the patient with portal hypertension
-
J Bosch R Mastai D Kravetz M Navasa J Rodes 1986 Hemodynamic evaluation of the patient with portal hypertension Semin Liver Dis 6 309 317 (Pubitemid 17219026)
-
(1986)
Seminars in Liver Disease
, vol.6
, Issue.4
, pp. 309-317
-
-
Bosch, J.1
Mastai, R.2
Kravetz, D.3
-
18
-
-
35648983411
-
New angiotensin II type 1 receptor blocker olmesartan improves portal hypertension in patients with cirrhosis
-
DOI 10.1111/j.1872-034X.2007.00165.x
-
H Hidaka S Kokubu T Nakazawa Y Okuwaki K Ono M Watanabe 2007 New angiotensin II type 1 receptor blocker olmesartan improves portal hypertension in patients with cirrhosis Hepatol Res. 37 1011 1017 (Pubitemid 350028327)
-
(2007)
Hepatology Research
, vol.37
, Issue.12
, pp. 1011-1017
-
-
Hidaka, H.1
Kokubu, S.2
Nakazawa, T.3
Okuwaki, Y.4
Ono, K.5
Watanabe, M.6
Shibuya, A.7
Saigenji, K.8
-
19
-
-
43949084102
-
Portal hypertension and variceal bleeding - Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference
-
DOI 10.1002/hep.22273
-
G Garcia-Tsao J Bosch RJ Groszmann 2008 Portal hypertension and variceal bleeding-unresolved issues. Summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver single-topic conference Hepatology. 47 1764 1772 (Pubitemid 351702758)
-
(2008)
Hepatology
, vol.47
, Issue.5
, pp. 1764-1772
-
-
Garcia-Tsao, G.1
Bosch, J.2
Groszmann, R.J.3
-
20
-
-
28144455912
-
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis
-
DOI 10.1056/NEJMoa044456
-
RJ Groszmann G Garcia-Tsao J Bosch ND Grace AK Burroughs R Planas 2005 Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis N Engl J Med 353 2254 2261 (Pubitemid 41697288)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.21
, pp. 2254-2261
-
-
Groszmann, R.J.1
Garcia-Tsao, G.2
Bosch, J.3
Grace, N.D.4
Burroughs, A.K.5
Planas, R.6
Escorsell, A.7
Garcia-Pagan, J.C.8
Patch, D.9
Matloff, D.S.10
Gao, H.11
Makuch, R.12
-
21
-
-
0034120267
-
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
-
R Bataller P Gines JM Nicolas MN Gorbig E Garcia-Ramallo X Gasull 2000 Angiotensin II induces contraction and proliferation of human hepatic stellate cells Gastroenterology 118 1149 1156 (Pubitemid 30346992)
-
(2000)
Gastroenterology
, vol.118
, Issue.6
, pp. 1149-1156
-
-
Bataller, R.1
Gines, P.2
Nicolas, J.M.3
Gorbig M.Nieves4
GarciaRamallo, E.5
Gasull, X.6
Bosch, J.7
Arroyo, V.8
Rodes, J.9
-
22
-
-
0031012401
-
The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide
-
D Rockey 1997 The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide Hepatology. 25 2 5 (Pubitemid 27014976)
-
(1997)
Hepatology
, vol.25
, Issue.1
, pp. 2-5
-
-
Rockey, D.1
-
24
-
-
0037903052
-
Portal pressure response to losartan compared with propranolol in patients with cirrhosis
-
DOI 10.1111/j.1572-0241.2003.07497.x
-
BK De K Bandyopadhyay TK Das D Das BK Biswas D Majumdar 2003 Portal pressure response to losartan compared with propranolol in patients with cirrhosis Am J Gastroenterol 98 1371 1376 (Pubitemid 36741536)
-
(2003)
American Journal of Gastroenterology
, vol.98
, Issue.6
, pp. 1371-1376
-
-
De, B.K.1
Bandyopadhyay, K.2
Das, T.K.3
Das, D.4
Biswas, P.K.5
Majumdar, D.6
Mandal, S.K.7
Ray, S.8
Dasgupta, S.9
-
25
-
-
0034898990
-
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
-
M Schepke E Werner E Biecker P Schiedermaier J Heller M Neef 2001 Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension Gastroenterology 121 389 395 (Pubitemid 32729386)
-
(2001)
Gastroenterology
, vol.121
, Issue.2
, pp. 389-395
-
-
Schepke, M.1
Werner, E.2
Biecker, E.3
Schiedermaier, P.4
Heller, J.5
Neef, M.6
Stoffel-Wagner, B.7
Hofer, U.8
Caselmann, W.H.9
Sauerbruch, T.10
-
26
-
-
33144458362
-
Arterial hypertension in cirrhosis: Arterial compliance, volume distribution, and central haemodynamics
-
DOI 10.1136/gut.2005.064329
-
JH Henriksen S Fuglsang F Bendtsen S Moller 2006 Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics Gut. 55 380 387 (Pubitemid 43268279)
-
(2006)
Gut
, vol.55
, Issue.3
, pp. 380-387
-
-
Henriksen, J.H.1
Fuglsang, S.2
Bendtsen, F.3
Moller, S.4
-
27
-
-
77955304201
-
Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: A systematic review and meta-analysis
-
P Tandon JG Abraldes A Berzigotti JC Garcia-Pagan J Bosch 2010 Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis J Hepatol 53 273 282
-
(2010)
J Hepatol
, vol.53
, pp. 273-282
-
-
Tandon, P.1
Abraldes, J.G.2
Berzigotti, A.3
Garcia-Pagan, J.C.4
Bosch, J.5
|